theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Nuclear Medicine

Palliation   

Questions discussed in this category


Can you give Pluvicto with concurrent palliative EBRT?
If so, do you modify your external beam dose? This question is part of our collaboration with ASTRO to highlight impactful data from the 2026 Multidi...
2 Answers available
17105


Papers discussed in this category


Int J Radiat Oncol Biol Phys, 2019 Oct 10
Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy.

EJNMMI physics, 2023 Feb 09
Investigation of image-based lesion and kidney dosimetry protocols for Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisition.

N Engl J Med, 2021 Jun 23
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025 Dec 03
Safety of the Combination of External Beam Radiotherapy with 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer.

Practical radiation oncology, 2025 Apr 22
Combination Metastasis-Targeted External Beam Radiation Therapy With 177Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate Cancer.

Related Topics in Nuclear Medicine

  • Radiation Oncology
  • Genitourinary Cancers
  • Medical Oncology
  • Prostate Cancer
  • ASTRO 2026
  • Urology
  • Hematology
  • Urologic Oncology
  • Gastrointestinal Cancers
  • Radioligand Therapy

Copyright © 2026 theMednet
All Rights Reserved.